Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,968 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors associated with improvement of fasting plasma glucose level by mealtime dosing of a rapid-acting insulin analog in type 2 diabetes.
Takamura T, Sakurai M, Nakamura M, Shimizu A, Ota T, Misu H, Takeshita Y, Tsuchiyama N, Kurita S, Ando H, Kaneko S. Takamura T, et al. Among authors: shimizu a. Diabetes Res Clin Pract. 2007 Mar;75(3):278-84. doi: 10.1016/j.diabres.2006.07.019. Epub 2006 Oct 27. Diabetes Res Clin Pract. 2007. PMID: 17069922 Clinical Trial.
Pharmacokinetics and pharmacodynamics of insulin aspart in patients with type 2 diabetes: assessment using a meal tolerance test under clinical conditions.
Ando H, Kurita S, Shimizu A, Kato K, Ishikura K, Taji K, Uno M, Takeshita Y, Misu H, Fujimura A, Kaneko S, Takamura T. Ando H, et al. Among authors: shimizu a. Clin Exp Pharmacol Physiol. 2012 Jun;39(6):528-34. doi: 10.1111/j.1440-1681.2012.05708.x. Clin Exp Pharmacol Physiol. 2012. PMID: 22642657 Clinical Trial.
Insulin-glucagon-like peptide-1 receptor agonist relay and glucagon-like peptide-1 receptor agonist first regimens in individuals with type 2 diabetes: A randomized, open-label trial study.
Takeshita Y, Kita Y, Tanaka T, Goto H, Nakano Y, Teramura C, Enyama Y, Takamura T; Establishment of Rationale for Antiaging Diabetic Medicine (ERA-DM) Study Group. Takeshita Y, et al. J Diabetes Investig. 2022 Jun;13(6):965-974. doi: 10.1111/jdi.13749. Epub 2022 Feb 8. J Diabetes Investig. 2022. PMID: 35034428 Free PMC article. Clinical Trial.
Gene expression profiles in peripheral blood mononuclear cells reflect the pathophysiology of type 2 diabetes.
Takamura T, Honda M, Sakai Y, Ando H, Shimizu A, Ota T, Sakurai M, Misu H, Kurita S, Matsuzawa-Nagata N, Uchikata M, Nakamura S, Matoba R, Tanino M, Matsubara K, Kaneko S. Takamura T, et al. Among authors: shimizu a. Biochem Biophys Res Commun. 2007 Sep 21;361(2):379-84. doi: 10.1016/j.bbrc.2007.07.006. Epub 2007 Jul 16. Biochem Biophys Res Commun. 2007. PMID: 17651698
2,968 results